Speelex’s Post

What makes #HomeTrial visits a great option for your studies? Patients with the option of home trial visits are less likely to withdraw from study participation. Additionally, home trial visits reduce the number of out-of-window (OOW), canceled, or missed visits, leading to fewer protocol deviations and shorter study timelines. See more on how Firma Clinical Research is #GuidingClinicalTrialsHome 🏡 https://bit.ly/3FDChQs #firmaclinicalresearch #clinicalresearch #clinicaltrials #hometrialservices #dct #dataservices #hometrial #pharmaceutical  #centralpharmacy #blooddraws #samplecollections #decentralizedtrials #CRO #patientcare #pharma #biotech #healthcare #patientexperience #drugtrials #drugdevelopment #lifescience #decentralizedclinicaltrials #hybridtrials #biopharma #clinicaloperations #clinops #CRA #businessdevelopment #phlebotomist

We all know how challenging it can be to integrate a #decentralized strategy into our clinical trials. But with Firma Clinical Research, we don't have to face those challenges alone. Their in-home trial visit program is a proven decentralized approach that is quick to implement, efficient to manage, and incredibly effective for sponsors, sites, and participants alike. If you're looking for the DCT support you need, look no further than Firma. They're #GuidingClinicalTrialsHome. Check out their program here ➡️ https://bit.ly/3nuYczp #firmaclinicalresearch #clinicalresearch #clinicaltrials #hometrialservices #dct #dataservices #hometrial #pharmaceutical  #centralpharmacy #blooddraws #samplecollections #decentralizedtrials #CRO #patientcare #pharma #biotech #healthcare #patientexperience #drugtrials #drugdevelopment #lifescience #decentralizedclinicaltrials #hybridtrials #biopharma #clinicaloperations #clinops #CRA #businessdevelopment #phlebotomist

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) CEO James Graham joins Proactive to talk through significant progress in the journey of RECCE® 327 (R327) for treating #UrinaryTractInfections (UTI) and urosepsis. The company has completed dosing in its Phase 1/2 clinical trial, which focused on evaluating R327's safety and pharmacokinetics at fast infusion rates. Following the completion of this phase of the trial, an independent safety committee will assess the data. This analysis is crucial for advancing to the next phase of research. Recruitment has already started for the subsequent cohort, aiming to further investigate R327's effects and prepare for an efficacy trial. The ongoing studies are stepping stones towards potentially establishing R327 as a frontline treatment for #UTI and #urosepsis. Recce is now not far from transitioning into an efficacy trial. Watch at #Proactive #ProactiveInvestors #ASX #OTC #RCE #RECEF #Biotech #Biopharmaceutcials #AntiInfectives Jonathan Jackson https://lnkd.in/emcwkZtW

Short video interview series #ExploreWithJeeva episode 6 of 14 is Live! Pharmaceutical Outsourcing asked Harsha K Rajasimha, Ph.D., our Founder & CEO: "How does technology foster meaningful patient engagement throughout the clinical trial journey? How does patient feedback influence study protocol?" He states patient education regarding the clinical trial is essential, highlighting the risks and benefits prospect patients get from these clinical trials. He also explains how technology helps patients to make informed choices in enrolling themselves and stay engaged till the end of the clinical trials. Watch the other episodes here! 🎧✨ https://lnkd.in/gH4f9hjh #jeevaclinicaltrials #clinicaltrials #clinicalresearch #informedconsent #patientengagement

Firma Clinical Research's #HomeTrial services expand your reach. 🌎 Make clinical trial participation possible for patients who otherwise may not have the option, and expand your reach for any type of patient population. As the leading independent home trial services provider, Firma Clinical Research is the first choice for sponsors and sites. ✅ 45k + patient visits complete ✅ 70+ countries ✅ 98% within protocol window ✅ 4,500+ network of healthcare providers #EveryTrialEveryPatient → https://bit.ly/3nuYczp #firmaclinicalresearch #clinicalresearch #clinicaltrials #hometrialservices #dct #dataservices #hometrial #pharmaceutical  #centralpharmacy #blooddraws #samplecollections #decentralizedtrials #CRO #patientcare #pharma #biotech #healthcare #patientexperience #drugtrials #drugdevelopment #lifescience #decentralizedclinicaltrials #hybridtrials #biopharma #clinicaloperations #clinops #CRA #businessdevelopment #phlebotomist

A few weeks ago Liz Clark and I, as co-chairs of the Working with Patients & Communities Forum, convened one of the Deep Dive sessions at the Faculty of Pharmaceutical Medicine annual symposium. The session was about patient engagement in the development of target product profiles (TPPs) and we had some fantastic speaker and faciliators in Constance Takawira Lorna Allen Rebecca Holmes Marta Garcia Manrique and Emma Harvey BSc MBBS MRCP FFPM Here I’m reporting back in full plenary what the main takeaways were from the session. ➡️Early & continous engagement ➡️Transparency & trust ➡️Multi-stakeholder representation ➡️Adequate resourcing #patientcentricty #patientcentric #patientcentred #patientengagement #pharma #pharmaceuticals #medicines #patientadvocacy #patientadvocate #drugdevelopment #clinicalresearch #research

Inconvenient site locations, schedule conflicts, logistical concerns, financial constraints, and missed visits all lead to patient dropout and high non-compliance rates. 👎🏽 #DecentralizedClinicalTrial strategy that can increase trial participation of eligible and diverse patients – regardless of study duration, frequency of visits, disease state or distance to study site. See why Firma Clinical Research assists with #GuidingClinicalTrialsHome to retain patients → https://lnkd.in/eKuugZ85 #firmaclinicalresearch #clinicalresearch #clinicaltrials #hometrialservices #dct #dataservices #hometrial #pharmaceutical  #centralpharmacy #blooddraws #samplecollections #decentralizedtrials #CRO #patientcare #pharma #biotech #healthcare #patientexperience #drugtrials #drugdevelopment #lifescience #decentralizedclinicaltrials #hybridtrials #biopharma #clinicaloperations #clinops #CRA #businessdevelopment #phlebotomist

Biosimilars offer safe, effective and more affordable treatment options for patients, while also generating competition and lowering prices for health systems. It's a win-win. Teva Pharmaceuticals recently announced the FDA approval of a biosimilar for the treatment of multiple autoimmune diseases, in partnership with Alvotech. And this is just the beginning for Teva. We have 16 biosimilars in our pipeline, many as part of strategic partnerships that make us even stronger. I’ll keep sharing more as these treatments become available, helping to improve access to medicines for patients around the world. Learn more about biosimilars at Teva: https://lnkd.in/dHZaUhyq #tevapharm #pivottogrowth #biosimilars #accesstomedicines #tevaproud

Next up in our Clinical Market Spotlight series is drug delivery! Drug delivery systems revolutionized the way medications are administered, helping to enhance treatment and patient outcomes. ➡️ Did you know? Drug delivery devices span a wide range of healthcare applications, including pharmaceutical systems, oncology, diabetes care, and medication management. ➡️ Examples of products in this space include injection/auto-injection technology, surgical devices, and respiratory devices like the dry powdered inhaler in the image below. Click below to learn more about Viant's drug delivery capabilities and stay tuned for more from our Clinical Market Spotlight series! https://lnkd.in/gWsWZvNr #Viant #medicaldevice #medtech #healthcare #drugdelivery #respiratory #pharmaceutical #diabetes

We understand the importance of convenience and comfort when it comes to clinical trial participation. That's why Firma Clinical Research offers the option for study subjects to complete selected study visits from the comfort of their own homes. With Firma Clinical Research home trial visits, safety monitoring, meeting study endpoints, and completing studies within timelines has never been easier. Check out how three of our clients utilized our services to increase participation in their trials. #trial 🏠💻 https://bit.ly/3tWPxua #firmaclinicalresearch #clinicalresearch #clinicaltrials #hometrialservices #dct #dataservices #hometrial #pharmaceutical  #centralpharmacy #blooddraws #samplecollections #decentralizedtrials #CRO #patientcare #pharma #biotech #healthcare #patientexperience #drugtrials #drugdevelopment #lifescience #decentralizedclinicaltrials #hybridtrials #biopharma #clinicaloperations #clinops #CRA #businessdevelopment #phlebotomist